View More View Less
  • 1 Institute for Health Promotion and Sport Sciences, Eötvös Loránd University, Budapest, Hungary
  • | 2 Department of Physiology and Neurobiology, Institute for Health Promotion and Sport Sciences, Eötvös Loránd University, Budapest, Hungary
  • | 3 Institute for Health Promotion and Sport Sciences, Eötvös Loránd University, Bogdánfy Ödön u. 10, H-1117, Budapest, Hungary
Restricted access

Abstract

Effects of the colour of curatives, of previous experiences and expectations, and of personality variables upon the generation of non-specific adverse (nocebo) effects of drugs were studied in a double-blind, randomized experiment. Thirty-eight female undergraduate students completed questionnaires (experiences, expectancies, state anxiety (STAI-S), dispositional optimism (LOT-R), somatosensory amplification (SSAS), somatic symptoms (PHQ-15)), then randomly ingested a white or red NSAID tablet (200-mg ibuprofen), and monitored themselves for 10 min for symptoms. According to a regression analysis, predictors of experienced symptoms were personal experiences with and expectations of side effects, and SSAS and PHQ-15 scores. Regarding the 14 monitored symptoms, significant differences between red and white tablets were found in five cases (irritability/agitation, palpitation vs. drowsiness, blurred vision, heartburn). Better understanding of personality and situational factors causing nocebo effects could help to identify and to avoid them.

  • [1]. H. Benson R. Friedman 1996 Harnessing the power of the placebo effect and renaming it “remembered wellness” Annu. Rev. Med. 47 193199.

    • Search Google Scholar
    • Export Citation
  • [2]. R. R. Bootzin E. T. Bailey 2005 Understanding placebo, nocebo, and iatrogenic treatment effects J. Clin. Psychol. 61 7 871880.

  • [3]. M. M. Reidenberg D. T. Lowenthal 1968 Adverse nondrug reactions New Engl. J. Med. 279 13 678679.

  • [4]. P. Rosenzweig S. Brohier A. Zipfel 1995 The placebo effect in healthy volunteers: influence of experimental conditions on physiological parameters during phase I studies Br. J. Clin. Pharmacol. 39 6 657664.

    • Search Google Scholar
    • Export Citation
  • [5]. A. J. Barsky R. Saintfort M. P. Rogers J. F. Borus 2002 Nonspecific medication side effects and the nocebo phenomenon JAMA 287 5 622627.

    • Search Google Scholar
    • Export Citation
  • [6]. S. Stewart-Williams 2004 The placebo puzzle: putting together the pieces Health Psychol. 23 2 198206.

  • [7]. I. Kirsch 2004 Conditioning, expectancy, and the placebo effect: comment on Stewart-Williams and Podd (2004) Psychol. Bull. 130 2 341343.

    • Search Google Scholar
    • Export Citation
  • [8]. S. Stewart-Williams J. Podd 2004 The placebo effect: dissolving the expectancy versus conditioning debate Psychol. Bull. 130 2 324340.

    • Search Google Scholar
    • Export Citation
  • [9]. M. E. Hyland B. Whalley A. W. A. Geraghty 2007 Dispositional predictors of placebo responding: a motivational interpretation of flower essence and gratitude therapy J. Psychosom. Res. 62 3 331340.

    • Search Google Scholar
    • Export Citation
  • [10]. J. Link R. Haggard K. Kelly D. Forrer 2006 Placebo/nocebo symptom reporting in a sham herbal supplement trial Eval. Health Prof. 29 4 394406.

    • Search Google Scholar
    • Export Citation
  • [11]. R. Thomson 1982 Side effects and placebo amplification Br. J. Psychiatry 140 6468.

  • [12]. F. Benedetti M. Amanzio C. Casadio A. Oliaro G. Maggi 1997 Blockade of nocebo hyperalgesia by the cholecystokinin antagonist proglumide Pain 71 2 135140.

    • Search Google Scholar
    • Export Citation
  • [13]. S. Ross L. W. Buckalew 1985 Placebo agentry: assessment of drug and placebo effects L. White B. Tursky G. Schwartz Placebo -Theory, Research, and Mechanisms Guilford New York 6782.

    • Search Google Scholar
    • Export Citation
  • [14]. R. Brown 2006 Medically unexplained symptoms: a new model Psychiatry 5 2 4347.

  • [15]. I. Kirsch 1997 Specifying nonspecifics: psychological mechanisms of placebo effects A. Harrington The Placebo Effect. An Interdisciplinary Exploration Harvard University Press Cambridge 166186.

    • Search Google Scholar
    • Export Citation
  • [16]. A. Geers S. Helfer K. Kosbab P. Weiland S. Landry 2005 Reconsidering the role of personality in placebo effects: Dispositional optimism, situational expectations, and the placebo response J. Psychosom. Res. 58 2 121127.

    • Search Google Scholar
    • Export Citation
  • [17]. J. M. Ferguson X. R. Alprazolam 1993 Patient acceptability, safety, and tolerability Psychiatr. Ann. 23 2026.

  • [18]. J. W. Pennebaker 1994 Psychological bases of symptom reporting: perceptual and emotional aspects of chemical sensitivity Toxicol. Ind. Health 10 4 497511.

    • Search Google Scholar
    • Export Citation
  • [19]. E. Uhlenhuth P. E. Alexander G. Dempsey W. Jones B. S. Coleman A. M. Swiontek 1998 Medication side effects in anxious patients: Negative placebo responses? J. Affect. Disord. 47 1 183190.

    • Search Google Scholar
    • Export Citation
  • [20]. P. Spinhoven A. J. Willem van der Does 1997 Somatization and somatosensory amplification in psychiatric outpatients: An explorative study Compr. Psychiatry 38 2 9397.

    • Search Google Scholar
    • Export Citation
  • [21]. K. Kroenke 2006 Physical symptom disorder: a simpler diagnostic category for somatization-spectrum conditions J. Psychosom. Res. 60 4 335339.

    • Search Google Scholar
    • Export Citation
  • [22]. R. Keeley 2002 When are medication side effects due to the nocebo phenomenon? JAMA 287 19 2503.

  • [23]. Y. Nestoriuc E. J. Orav M. H. Liang R. Horne A. J. Barsky 2010 Prediction of nonspecific side effects in rheumatoid arthritis patients by beliefs about medicines Arthritis Care Res. 62 6 791799.

    • Search Google Scholar
    • Export Citation
  • [24]. A. J. Barsky G. Wyshak G. L. Klerman 1990 The Somatosensory Amplification Scale and its relationship to hypochondriasis J. Psychiatr. Res. 24 4 323334.

    • Search Google Scholar
    • Export Citation
  • [25]. J. Mailloux J. Brener 2002 Somatosensory amplification and its relationship to heartbeat detection ability Psychosom. Med. 64 2 353357.

    • Search Google Scholar
    • Export Citation
  • [26]. M. Nakao A. J. Barsky M. Nishikitani E. Yano K. Murata 2007 Somatosensory amplification and its relationship to somatosensory, auditory, and visual evoked and event-related potentials (P300) Neurosci. Lett. 415 2 185189.

    • Search Google Scholar
    • Export Citation
  • [27]. J. W. Pennebaker 1982 The Psychology of Physical Symptoms Springer New York.

  • [28]. A. J. Schmidt D. J. Wolfs-Takens J. Oosterlaan M. A. van den Hout 1994 Psychological mechanisms in hypochondriasis: attention-induced physical symptoms without sensory stimulation Psychother. and Psychosom. 61 1 117120.

    • Search Google Scholar
    • Export Citation
  • [29]. A. J. M. de Craen P. J. Roos A. L. de Vries J. Kleijnen 1996 Effect of colour of drugs: systematic review of perceived effect of drugs and of their effectiveness BMJ 313 7072 16241626.

    • Search Google Scholar
    • Export Citation
  • [30]. D. E. Moerman 2002 Meaning, Medicine and the’ Placebo Effect’ Cambridge University Press Cambridge.

  • [31]. K. Schapira H. A. McClelland N. R. Griffiths D. J. Newell 1970 Study on the effects of tablet colour in the treatment of anxiety states Br. Med. J. 2 5707 446449.

    • Search Google Scholar
    • Export Citation
  • [32]. A. D. Cattaneo P. E. Lucchelli G. Filipucci 1970 Sedative effects of placebo treatment Eur. J. Clin. Pharmacol. 3 4345.

  • [33]. F. Köteles G. Bárdos 2007 Tabletták várt hatása és színe/mérete közötti kapcsolatok Mentálhigiéné es Pszichoszomatika 8 4 277290.

    • Search Google Scholar
    • Export Citation
  • [34]. F. Köteles G. Bárdos 2009 Tabletták perceptuális jellemzői által generált mellékhatás-elvárások és pszichológiai hátterük Mentálhigiéné es Pszichoszomatika 10 1 4762.

    • Search Google Scholar
    • Export Citation
  • [35]. C. D. Spielberger R. L. Gorsuch R. E. Lushene 1970 Manual for the State-Trait Anxiety Inventory Consulting Psychologists Press Palo Alto, CA.

    • Search Google Scholar
    • Export Citation
  • [36]. K. Sipos M. Sipos C. D. Spielberger 1994 A State-Trait Anxiety Inventory (STAI) magyar változata F. Mérei F. Szakács Pszichodiagnosztikai vademecum Nemzeti Tankönyvkiadó Budapest.

    • Search Google Scholar
    • Export Citation
  • [37]. M. F. Scheier C. S. Carver M. W. Bridges 1994 Distinguishing optimism from neuroticism (and trait anxiety, self-mastery, and self-esteem): A reevaluation of the Life Orientation Test J. Pers. Soc. Psychol. 67 6 10631078.

    • Search Google Scholar
    • Export Citation
  • [38]. S. Vautier E. Raufaste 2006 Configural instability of data from the Life Orientation Test — Revised Personality Individ. Differ. 40 8 15111518.

    • Search Google Scholar
    • Export Citation
  • [39]. A. Geers K. Kosbab S. Helfer P. Weiland J. Wellman 2007 Further evidence for individual differences in placebo responding: an interactionist perspective J. Psychosom. Res. 62 5 563570.

    • Search Google Scholar
    • Export Citation
  • [40]. M. Bérdi F. Köteles 2010 Az optimizmus mérése: az Életszemlélet Teszt átdolgozott változatának (LOT-R) pszichometriai jellemzői hazai mintán Magyar Pszichológiai Szemle 65 2 273294.

    • Search Google Scholar
    • Export Citation
  • [41]. K. Kroenke R. L. Spitzer J. B. W. Williams 2002 The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms Psychosom. Med. 64 2 258266.

    • Search Google Scholar
    • Export Citation
  • [42]. A. Stauder B. Konkoly Thege 2006 Az észlelt stressz kérdőív (PSS) magyar verziójának jellemzői Mentálhigiéné és Pszichoszomatika 7 3 203216.

    • Search Google Scholar
    • Export Citation
  • [43]. F. Köteles H. Gémes G. Papp P. Túróczi A. Pásztor A. Freyler R. Szemerszky G. Bárdos 2009 A Szomatoszenzoros Amplifikáció Skála (SSAS) magyar változatának validálása Mentálhigiéné és Pszichoszomatika 10 4 321335.

    • Search Google Scholar
    • Export Citation
  • [44]. A. J. Barsky E. J. Orav D. K. Ahern M. P. Rogers S. D. Gruen M. H. Liang 1999 Somatic style and symptom reporting in rheumatoid arthritis Psychosomatics 40 5 396403.

    • Search Google Scholar
    • Export Citation
  • [45]. F. Köteles A. Tóth G. Bárdos 2011 Expectations of medicine adverse effects: Perceptual characteristics of tablets and personality background Clin. Exp. Med. J. 5 199202.

    • Search Google Scholar
    • Export Citation
  • [46]. F. Benedetti M. Lanotte L. Lopiano L. Colloca 2007 When words are painful: unraveling the mechanisms of the nocebo effect Neuroscience 147 2 260271.

    • Search Google Scholar
    • Export Citation
  • [47]. F. Köteles I. Komsa G. Bárdos 2010 The effect of perceptual characteristics of tablets upon patient's choice Clinical and Experimental Medical Journal 4 1 99104.

    • Search Google Scholar
    • Export Citation
  • [48]. S. C. Shea 2006 Improving Medication Adherence Lippincott Williams & Wilkins Philadelphia.

  • [49]. P. C. Gotzsche 1994 Is there logic in the placebo? Lancet 344 8927 925926.

Clinical and Experimental Medical Journal
Language English
Size  
Year of
Foundation
2007
Publication
Programme
ceased
Volumes
per Year
 
Issues
per Year
 
Publisher Akadémiai Kiadó
Publisher's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245
Responsible
Publisher
Chief Executive Officer, Akadémiai Kiadó
ISSN 2060-6249 (Print)
ISSN 2060-968X (Online)

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Feb 2022 2 0 0
Mar 2022 2 0 0
Apr 2022 5 5 5
May 2022 1 1 1
Jun 2022 3 0 0
Jul 2022 1 1 0
Aug 2022 0 0 0